SCM
EIGR
Soleus Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-219,000
| Closed | -$1.65M | – | 94 |
|
|
2022
Q3 | $1.65M | Sell |
219,000
-627,000
| -74% | -$4.72M | 0.22% | 59 |
|
|
2022
Q2 | $5.33M | Buy |
846,000
+63,000
| +8% | +$397K | 0.83% | 36 |
|
|
2022
Q1 | $6.5M | Buy |
+783,000
| New | +$6.5M | 0.84% | 35 |
|
|
2021
Q4 | – | Sell |
-213,519
| Closed | -$1.43M | – | 89 |
|
|
2021
Q3 | $1.43M | Hold |
213,519
| – | – | 0.22% | 61 |
|
|
2021
Q2 | $1.82M | Hold |
213,519
| – | – | 0.28% | 53 |
|
|
2021
Q1 | $1.89M | Buy |
213,519
+27,800
| +15% | +$246K | 0.34% | 52 |
|
|
2020
Q4 | $2.28M | Sell |
185,719
-286,839
| -61% | -$3.52M | 0.3% | 36 |
|
|
2020
Q3 | $3.85M | Sell |
472,558
-147,708
| -24% | -$1.2M | 2.04% | 20 |
|
|
2020
Q2 | $5.95M | Buy |
620,266
+215,059
| +53% | +$2.06M | 3.39% | 7 |
|
|
2020
Q1 | $2.76M | Buy |
405,207
+199,800
| +97% | +$1.36M | 3.21% | 11 |
|
|
2019
Q4 | $3.06M | Buy |
+205,407
| New | +$3.06M | 2.95% | 13 |
|